RedHill Biopharma Ltd.RDHLEarnings & Financial Report
Nasdaq
RedHill Biopharma Ltd. is a specialty biopharmaceutical firm focused on developing and commercializing innovative therapeutics for gastrointestinal disorders, inflammatory conditions, and infectious diseases. It operates mainly in North American and European markets, delivering prescription treatments for unmet clinical needs and partnering with healthcare stakeholders to expand product access.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| CVI Investments, Inc. | 4.90% | 672.5M | ▼ -1.00pp | 2024-11-14 |
| Mitchell P. Kopin | 4.00% | 1.3M | — | 2024-02-02 |
| Empery Asset Management, LP | 3.19% | 647.8K | — | 2024-01-08 |
| Sabby Volatility Warrant Master Fund, Ltd. | — | 8.2K | — | 2024-01-02 |
Insider Transactions
Net 90d: −$1.6K · buys $0 / sells $1.6KRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-06 | Gilead Raday | Chief Operating Officer | Sell (open market) | 15.74M | $0.00 | $1.6K |
1–1 of 1